Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Pharmacol Res. 2009 Dec 17;61(5):466–472. doi: 10.1016/j.phrs.2009.12.001

Fig. 3.

Fig. 3

Inhibitory effects of p65 siRNA on the upregulation of RhoA induced by TNF-α (10 ng/mL, for 24 h) in hBSMCs. Proteins of hBSMCs were assayed for RhoA by immunoblotting. (Upper photos) Typical blots for RhoA and β-actin. The expression levels of RhoA are summarized in lower panel. Values are the means with S.E.M. from 3 independent experiments. ***p < 0.001 vs. Cont siRNA, ##p < 0.01 and ###p < 0.001 vs. TNF-α+ Cont siRNA by two-way ANOVA with post hoc Bonferroni/Dunn’s test.

HHS Vulnerability Disclosure